Rankings
▼
Calendar
SCYX FY 2012 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
FY 2012 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$17M
Gross Profit
$2M
14.7% margin
Operating Income
-$8M
-46.2% margin
Net Income
-$11M
-68.2% margin
EPS (Diluted)
$-72.58
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$358,000
Balance Sheet
Total Assets
$12M
Total Liabilities
$31M
Stockholders' Equity
-$19M
Cash & Equivalents
$2M
← FY 2013
All Quarters